Female resistance to the metabolic benefits of protein restriction is reversed by ovariectomy in mice

This study demonstrates that ovarian hormones are responsible for the reduced metabolic benefits of low-protein diets in female mice, as removing the ovaries sensitizes females to these benefits, making their response similar to that of males.

The Gist

Imagine your body is a high-performance car. For years, scientists have known that if you put less "premium fuel" (protein) into the engine, the car often runs cleaner, lasts longer, and avoids certain breakdowns like diabetes. This is the magic of Protein Restriction.

However, there's a catch: this magic trick works differently depending on who is driving.

The Gender Gap in the Lab

In previous studies, scientists found that male mice were like sports cars that responded beautifully to low-protein fuel. They got leaner, their blood sugar stabilized, and their engines ran more efficiently.

Female mice, on the other hand, were like heavy-duty trucks that just didn't care. When put on the same low-protein diet, they didn't lose weight or get the same health boost. They seemed "resistant" to the benefits.

The big question was: Why? Was it their genes? Their lifestyle? Or was it something else entirely?

The "Ovary" Switch

The researchers in this paper decided to test a bold hypothesis: Is the female resistance caused by the ovaries?

Think of the ovaries not just as reproductive organs, but as a control tower sending out hormonal signals that tell the body how to handle food. The team wondered if removing this control tower would change the female mice's reaction to the diet.

So, they set up an experiment with four groups of mice:

1. Normal Males (with testes)
2. Castrated Males (testes removed)
3. Normal Females (with ovaries)
4. Ovariectomized Females (ovaries removed)

They fed all of them either a standard diet (high protein) or a "Low Protein" diet (like a light, lean fuel mix).

The Big Reveal

The results were a plot twist:

• The Males: Whether they had their testes or not, they still responded well to the low-protein diet. The testes weren't the main reason they got healthy.
• The Normal Females: Just like before, they ignored the diet. No weight loss, no metabolic boost.
• The "Ovary-Free" Females: This is where the magic happened. Once the ovaries were removed, these female mice suddenly started acting like the males! They lost fat, improved their blood sugar, and got all the metabolic benefits of the low-protein diet.

The Analogy: Imagine the ovaries are like a brake pedal on a car. When the ovaries are present, they press the brake, stopping the body from reacting to the low-protein diet. When you remove the ovaries (ovariectomy), you release the brake, and the car (the mouse) finally accelerates toward better health.

What's Happening Under the Hood?

The scientists looked inside the cells to see what changed. They found that the ovaries were influencing the body's "nutrient sensors" (specifically a system called mTOR).

• With Ovaries: The sensors are tuned to hold onto fat and ignore the low-protein signal.
• Without Ovaries: The sensors reset. They start burning fat more efficiently and switching the body's metabolism to a "lean and mean" mode, just like the males.

Interestingly, the study also found that FGF21, a hormone often called the "master switch" for these benefits, went up in all the mice on the low-protein diet. This means the difference wasn't that females couldn't make the switch; it was that their ovaries were blocking the switch from actually turning on the benefits.

What Does This Mean for Humans?

This is the most exciting part. The researchers suggest that this might explain why older women (who naturally go through menopause and stop producing high levels of ovarian hormones) might benefit more from low-protein diets than younger women.

• Young Women: Their "brake pedal" (ovaries) is active, so a low-protein diet might not do much for their metabolism.
• Post-Menopausal Women: Their "brake pedal" is naturally released (due to lower hormone levels). Therefore, they might be the perfect candidates to get the anti-aging, diabetes-fighting benefits of eating less protein.

The Takeaway

This paper tells us that biology is not one-size-fits-all. What works for a man might not work for a woman, not because of their DNA, but because of their hormonal "control towers."

By understanding that the ovaries act as a gatekeeper for these metabolic benefits, doctors might one day be able to prescribe specific diets based on a person's age and hormonal status, helping more people live longer, healthier lives.

Technical Summary

1. Problem Statement

Dietary protein restriction (PR), specifically reducing protein intake to ~7% of total calories, is a well-established intervention that improves metabolic health, reduces adiposity, and extends lifespan in male mice and humans. However, a significant sexually dimorphic response exists: female mice exhibit a blunted or absent metabolic response to low-protein (LP) diets compared to males. The mechanisms underlying this resistance in females are undefined. The authors hypothesized that gonadal sex hormones (specifically ovarian hormones in females and testicular hormones in males) mediate this difference, potentially preventing females from reaping the metabolic benefits of PR.

2. Methodology

The study utilized a rigorous experimental design involving C57BL/6J mice to isolate the effects of sex, diet, and gonadal hormones.

• Subjects & Surgery: Male and female mice (7 weeks old) were subjected to gonadectomy at 5 weeks of age (prior to puberty).
  • Groups: Intact (Sham), Castrated (Cast), Ovariectomized (Ovx), and Sham controls for both sexes.
• Dietary Intervention: At 8 weeks, mice were randomized into two isocaloric diets for 12 weeks:
  • Control (CTL): 21% protein calories.
  • Low Protein (LP): 7% protein calories (carbohydrates replaced protein calories).
• Phenotypic Assessments:
  • Body Composition: Weekly body weight; bi-weekly lean/fat mass via EchoMRI.
  • Metabolic Function: Glucose Tolerance Tests (GTT), Insulin Tolerance Tests (ITT), Alanine Tolerance Tests, and HOMA2-IR calculations.
  • Energy Balance: Indirect calorimetry (Oxymax/CLAM-HC) to measure Energy Expenditure (EE), Respiratory Exchange Ratio (RER), and spontaneous activity.
  • Molecular Analysis:
    • Hormones: Plasma FGF21, testosterone, and estradiol via ELISA.
    • Lipidomics: Liver triglycerides (TG), cholesterol, and Oil Red O (ORO) staining for lipid droplet size.
    • Signaling Pathways: Western blotting for mTORC1/2 signaling components (p-S6K1, p-S6, p-4E-BP1, p-AKT) in liver and skeletal muscle.
    • Gene Expression: qPCR for lipolysis (Atgl, Lipe), lipogenesis (Fasn, Scd1, Dgat1), and thermogenesis (Ucp1, Cidea) markers in liver and inguinal white adipose tissue (iWAT).
• Statistical Analysis: Two-way and three-way ANOVA with Šidák's post-hoc testing; Principal Component Analysis (PCA) for phenotypic clustering.

3. Key Results

A. Body Weight and Composition

• Intact Females: Showed no significant reduction in body weight or fat mass when fed an LP diet compared to CTL, confirming their resistance.
• Ovariectomized (Ovx) Females: Reversed the resistance. Ovx mice fed an LP diet exhibited a ~25% reduction in fat mass and reduced body weight, phenotypically mirroring the response seen in intact males.
• Castrated (Cast) Males: Unlike Ovx females, castration did not significantly alter the male response to LP; Cast males still responded to LP, though the effect was slightly blunted compared to intact males.
• Lean Mass: All LP-fed groups (regardless of sex or surgery) lost lean mass, but Ovx LP females were the only group to show a significant reduction in adiposity relative to their CTL counterparts.

B. Energy Balance and FGF21

• Energy Expenditure (EE): LP diets increased EE during the dark cycle across all groups (Intact, Cast, Ovx, Sham), indicating that the lack of weight loss in intact females is not due to a failure to increase EE.
• FGF21: LP diets robustly induced plasma and hepatic Fgf21 expression in all groups. This rules out a failure to induce FGF21 as the cause of female resistance.
• Activity: Gonadectomy (both Cast and Ovx) reduced spontaneous activity, but this did not correlate with the metabolic benefits of LP.

C. Glucose Homeostasis

• Intact Females: LP diet did not significantly improve glucose tolerance.
• Ovx Females: LP diet significantly improved glucose tolerance and reduced fasting glucose, mirroring the response of intact males.
• Castrated Males: LP diet improved glucose tolerance, but castration itself improved baseline tolerance, making the diet effect less distinct.
• PCA: Principal Component Analysis confirmed that the phenotypic response to LP in Ovx females clustered with Intact Males, distinct from Intact Females and Cast Males.

D. Molecular Mechanisms

• mTOR Signaling:
  • Liver: LP diet reduced p-S6K1 (mTORC1 activity) in all groups. Sex and gonadectomy influenced baseline levels, but the diet effect was consistent.
  • Muscle: LP diet significantly reduced mTORC1 signaling (p-S6, p-4E-BP1) in Ovx females, recapitulating the male response. This effect was not observed in the liver of the same mice, suggesting tissue-specific regulation.
• Lipid Metabolism:
  • LP diets increased hepatic lipid storage (TG and cholesterol) and lipid droplet size in all groups.
  • iWAT Beiging: LP diets induced thermogenic gene expression (Ucp1, Cidea) in iWAT across all groups. However, gonadectomy itself also activated beiging, suggesting sex organs normally suppress this pathway.
• FGF21 Independence: Since FGF21 was induced in all groups but only Ovx females showed metabolic benefits, FGF21 induction alone is insufficient to drive the metabolic phenotype; downstream signaling (likely involving mTOR and lipid handling) is the differentiator.

4. Key Contributions

1. Identification of Ovarian Hormones as the Primary Barrier: The study definitively demonstrates that ovarian hormones are the primary mediators of female resistance to the metabolic benefits of protein restriction. Removing the ovaries (Ovx) sensitizes females to LP diets.
2. Decoupling of FGF21 and Metabolic Benefit: The authors show that while FGF21 is a necessary signal for LP benefits in males, its induction in females is not sufficient to confer metabolic health unless the ovarian hormonal environment is altered.
3. Tissue-Specific mTOR Regulation: The study highlights that the metabolic response to LP involves tissue-specific modulation of mTOR signaling, particularly in skeletal muscle, which is sensitive to the presence/absence of ovarian hormones.
4. Sex-Specific Dietary Recommendations: The findings challenge the "one-size-fits-all" approach to dietary protein restriction, suggesting that pre-menopausal women (analogous to intact females) may not benefit metabolically from severe protein restriction, whereas post-menopausal women (analogous to Ovx) might.

5. Significance

• Clinical Translation: This research suggests that post-menopausal women or women with ovarian insufficiency may be ideal candidates for protein-restricted diets to improve metabolic health, reduce adiposity, and manage diabetes. Conversely, pre-menopausal women might require different dietary strategies or hormonal considerations to achieve similar benefits.
• Aging Research: As ovarian function declines with age, the natural transition to a post-menopausal state may inherently "sensitize" older women to the benefits of PR, potentially explaining why some human studies show mixed results depending on the age and sex distribution of participants.
• Future Directions: The study underscores the necessity of including both sexes and considering reproductive status in preclinical metabolic studies. It opens new avenues for investigating specific ovarian hormones (e.g., estradiol) that antagonize the metabolic benefits of protein restriction.

Conclusion: The paper provides a mechanistic explanation for the sexually dimorphic response to protein restriction, identifying ovarian hormones as the critical factor suppressing metabolic benefits in female mice. By removing these hormones, females become metabolically responsive to LP diets, mirroring the robust improvements seen in males.